Skip to content

Clinical trials

Anxiety Disorders trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anxiety Disorders Country / region: Germany Clear all

133 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20013
20042
20054
20063
20072
20084
20092
20103
20113
20126
20131
20141
20155
20164
20174
20186
20197
202018
20219
20221
20239
202412
202516
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed83
Recruiting19
Unknown status19
Terminated5
Not yet recruiting3
Active, not recruiting3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Charite University, Berlin, Germany11
Ruhr University of Bochum10
Universitätsklinikum Hamburg-Eppendorf8
Heidelberg University5
Hannover Medical School4
Jacobs University Bremen gGmbH4
Philipps University Marburg4
Schön Klinik Berchtesgadener Land4
University of Witten/Herdecke4
Eli Lilly and Company3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anxiety Disorders133
Depressive Disorder18
Pain9
COVID-198
Mental Disorders8
Generalized Anxiety Disorder7
Pulmonary Disease, Chronic Obstructive6
Schizophrenia6
Arrhythmias, Cardiac4
Diabetes Mellitus, Type 24

Trials

Showing 51 to 75 of 133. Each trial links to its page on Pharma Observatory.

33 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.